These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Quality control of absolute bacteria removal filters. Pall DB Bull Parenter Drug Assoc; 1975; 29(4):192-204. PubMed ID: 1131463 [No Abstract] [Full Text] [Related]
3. PDA presentation at FDA Open Conference on Sterile Drug Manufacturing. Parenteral Drug Association. J Pharm Sci Technol; 1994; 48(1):4-6. PubMed ID: 8004417 [No Abstract] [Full Text] [Related]
4. [Purity requirements for drugs]. Battaglino G Ann Ist Super Sanita; 1982; 18(4):615-20. PubMed ID: 7188516 [No Abstract] [Full Text] [Related]
5. [Study concept of traditional Chinese medicine quality standards]. Chen J; Chen L; An Z; Chang Z; Yuan X; Zhan Y Zhong Yao Cai; 2002 Oct; 25(10):748-50. PubMed ID: 15562726 [TBL] [Abstract][Full Text] [Related]
6. [Problems of control of polymers used in drug technology]. Krówczyński L Polim Med; 1984; 14(1-4):5-12. PubMed ID: 6533635 [TBL] [Abstract][Full Text] [Related]
7. Panel discussion: Environmental sampling in an aseptic environment. III. Cross contamination control. Elias WF Bull Parenter Drug Assoc; 1974; 28(6):263-9. PubMed ID: 4455322 [No Abstract] [Full Text] [Related]
8. [Microbiological in-process control in drug manufacture]. Seyfarth VH Arzneimittelforschung; 1985; 35(1A):205-16. PubMed ID: 4039162 [TBL] [Abstract][Full Text] [Related]
9. [Flow of laminar air: use in sterile rooms]. Lumini E Boll Chim Farm; 1975 Jul; 114(7):361-74. PubMed ID: 1164445 [No Abstract] [Full Text] [Related]
10. [Cause and measure of short of quality control on Chinese medicine herbs]. Chen J; Chen L; An Z; Yu X; Zhan Y Zhong Yao Cai; 2003 Jan; 26(1):43-6. PubMed ID: 12858774 [TBL] [Abstract][Full Text] [Related]
11. An approach to establishing parenteral solution sterilization cycles. Korczynski MS; Peterson CL; Loshbaugh CC Bull Parenter Drug Assoc; 1974; 28(6):270-7. PubMed ID: 4455323 [No Abstract] [Full Text] [Related]
12. Panel discussion: environmental sampling in an aseptic environment. I. Microbiological environmental monitoring. Raiman HL Bull Parenter Drug Assoc; 1974; 28(6):253-60. PubMed ID: 4616742 [No Abstract] [Full Text] [Related]
13. Validation and routine operation of a sterile dry powder filling facility. Prout G J Parenter Sci Technol; 1982; 36(5):199-204. PubMed ID: 6927748 [No Abstract] [Full Text] [Related]
14. [Criteria of purity and specifications, an essential premise to the beginning of any toxicological investigation]. Gatti GL Ann Ist Super Sanita; 1982; 18(4):641-2. PubMed ID: 7188520 [No Abstract] [Full Text] [Related]
15. New particle counter for nondestructive monitoring of parenterals. Porter MC Bull Parenter Drug Assoc; 1975; 29(4):169-82. PubMed ID: 1131461 [No Abstract] [Full Text] [Related]
16. [Examples of purity criteria for steroid drugs]. Cavina G; Moretti G; Alimenti R; Gallinella B; Porrà R; Valvo L Ann Ist Super Sanita; 1982; 18(4):677-80. PubMed ID: 7188524 [No Abstract] [Full Text] [Related]
17. Filling vials aseptically while monitoring for bacterial contamination. Dirksen JW; Larsen RV Am J Hosp Pharm; 1975 Oct; 32(10):1031-2. PubMed ID: 1190216 [TBL] [Abstract][Full Text] [Related]
18. Loading and unloading of freeze-dryers: airborne contamination risks for aseptically manufactured sterile drug products. Ljungqvist B; Reinmüller B PDA J Pharm Sci Technol; 2007; 61(1):44-50. PubMed ID: 17390703 [TBL] [Abstract][Full Text] [Related]
19. Biological indicators in the pharmaceutical and the medical device industry. Pflug IJ; Odlaug TE J Parenter Sci Technol; 1986; 40(5):242-8. PubMed ID: 3540254 [No Abstract] [Full Text] [Related]
20. Risk management, cGMP, and the evolution of aseptic processing technology. Agalloco J; Akers J; Baseman H; Boeh R; Madsen R; Ostrove S; Pavell A PDA J Pharm Sci Technol; 2009; 63(1):8-10. PubMed ID: 19455938 [No Abstract] [Full Text] [Related] [Next] [New Search]